Towards personalized therapy for multiple sclerosis: limitations of observational data
Author:
Affiliation:
1. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
2. Division of Cardiovascular Medicine, Harvard Medical School, Boston, MA, USA
Publisher
Oxford University Press (OUP)
Subject
Clinical Neurology
Link
http://academic.oup.com/brain/article-pdf/141/5/e38/24724236/awy055.pdf
Reference7 articles.
1. Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints;Claggett;Biostatistics,2015
2. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response;Kalincik;Brain,2017
3. Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials;Kent;Int J Epidemiol,2016
4. Population-based validation of the prognostic model ADJUVANT! for early breast cancer;Olivotto;J Clin Oncol,2005
5. External validity of randomised controlled trials: “to whom do the results of this trial apply?”;Rothwell;Lancet,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis;Cochrane Database of Systematic Reviews;2023-09-08
2. Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-07
3. A Study on Machine Learning Techniques for Precision Medicine Recommendation;2023 International Conference on Intelligent Systems for Communication, IoT and Security (ICISCoIS);2023-02-09
4. Evolution of teriflunomide use in multiple sclerosis: A real-world experience;Journal of the Neurological Sciences;2022-07
5. Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making;BMC Medical Informatics and Decision Making;2021-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3